Adobe Inc (NASDAQ:ADBE) reported fiscal second-quarter earnings and revenue that beat expectations. The company also raised its annual revenue forecast thanks to strong demand for its artificial intelligence (AI) editing tools. At last glance, ADBE is up 14.7% to trade at $525.96.
In response, J.P. Morgan Securities upgraded the security to "overweight" from "neutral," and raised its price objective to $580 and $570. Six other analysts lifted their price targets as well. Coming into today, 23 of 32 firms in coverage called ADBE a "buy" or better, while the 12-month consensus target price of $615.99 is a 16.1% premium to current levels.
Shares are trading at their highest level since March, and on track for their biggest single-day percentage gain since March 2020. The equity is also eyeing its first close above the 60-day moving average since February, but remains down roughly 12% so far in 2024.
Options volume is today running at 18 times the intraday average amount, with 47,000 calls and 35,000 puts exchanged so far. The most popular contract is the weekly 6/14 550-strike call, where new positions are being bought to open. This means traders expect additional upside for ADBE before today's close.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
